Author： Fagiolini Andrea
Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.22, Iss.8, 2008-01, pp. : 655-669
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Recognition of bipolar disorder relieves substantial cost burden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 442, 2003-01 ,pp. :
Access to resources
Recommend
Burden of Bipolar Depression: Impact of Disorder and Medications on Quality of Life
CNS Drugs, Vol. 22, Iss. 5, 2008-01 ,pp. :
The fall and rise of economic studies of bipolar disorder
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 336, 2001-01 ,pp. :
CV outcomes similar with BP meds in metabolic syndrome
Inpharma, Vol. 1, Iss. 1629, 2008-01 ,pp. :